Literature DB >> 6227679

T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315).

T Jørgensen, B Bogen, K Hannestad.   

Abstract

Isolated variable region light chain 315 (VL-315), the VL domain of a myeloma protein of BALB/c origin, induces T cells of BALB/c (H-2d) mice that help the adoptive secondary anti-4-hydroxy-3-iodo-5-nitrophenylacetyl (NIP) antibody response to NIP-Fab315. The location of the epitope recognized by helper cells was examined with two fragments of VL-315, obtained by cleavage with cyanogen bromide at Met 87. Both N-terminal fragment 1-86 and C-terminal fragment 88-114/117 elicited BALB/c antibodies that bound to the respective fragments and to VL-315. By contrast, only fragment 88-114/117, which consists of the third hypervariable region, J region, and 5-7 amino acids of the C region, induced helper cells that augmented the anti-NIP response to NIP-Fab 315.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227679      PMCID: PMC2187159          DOI: 10.1084/jem.158.6.2183

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

2.  T helper lymphocytes recognize the VL domain of the isologous mouse myeloma protein 315.

Authors:  T Jørgensen; K Hannestad
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

3.  An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.

Authors:  J Hochman; D Inbar; D Givol
Journal:  Biochemistry       Date:  1973-03-13       Impact factor: 3.162

4.  Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315).

Authors:  E S Dugan; R A Bradshaw; E S Simms; H N Eisen
Journal:  Biochemistry       Date:  1973-12-18       Impact factor: 3.162

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  H--2-linked genes control immune response to V-domains of myeloma protein 315.

Authors:  T Jørgensen; K Hannestad
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Specificity of T and B lymphocytes for myeloma protein 315.

Authors:  T Jorgensen; K Hannestad
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

8.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

9.  Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins.

Authors:  S Sirisinha; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

10.  Recognition of lambda 1 and lambda 2 murine light chains by carrier-specific isologous T helper cells; effect of L-H chain assembly.

Authors:  B Bogen; T Jørgensen; K Hannestad
Journal:  Eur J Immunol       Date:  1983-05       Impact factor: 5.532

View more
  6 in total

1.  Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes.

Authors:  Jinsheng Weng; Soung-Chul Cha; Satoko Matsueda; Gheath Alatrash; Michael S Popescu; Qing Yi; Jeffrey J Molldrem; Michael Wang; Sattva S Neelapu; Larry W Kwak
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

2.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin.

Authors:  J E Hopper; W Sequeira; J Martellotto; E Papagiannes; L Perna; J L Skosey
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

4.  Fine specificity analysis of idiotype-specific suppressor factors that block a delayed-type hypersensitivity response to M315: evidence supporting a role for somatic mutations in the variable region of the lambda 2 chain of M315.

Authors:  N Sakato; T Azuma; H Fujio
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

5.  Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes.

Authors:  J Benjamin St Clair; Thiago Detanico; Katja Aviszus; Greg A Kirchenbaum; Merry Christie; John F Carpenter; Lawrence J Wysocki
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

6.  Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells.

Authors:  Agnete B Fredriksen; Inger Sandlie; Bjarne Bogen
Journal:  Front Oncol       Date:  2012-10-30       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.